Aug 2017

The 36th EBJIS (European Bone and Joint Infection Society) Annual Meeting (September 7-9, 2017)

PolyPid’s abstract “Enhanced bone healing of Gustilo III severe open tibia fractures treated by immediate implantation of antibiotic-formulated bone grafting” was accepted to the 36th Annual Meeting of the European Bone and Joint Infection Society which will be held in Nantes, France, on 7-9 September 2017. The abstract will be presented in the poster presentation.

Jun 2017

The 2017 BIO International Convention in San Diego (June 19-22, 2017)

PolyPid will take part at the BIO International Convention, the world’s largest conference in the field of life sciences, showcasing the world's leading companies and developments in the fields of medical technology and life sciences. PolyPid will be represented by Mr. Amir Weisberg (CEO) as well as Dr. Tamar Alon (CBD) and Dr. Dan Popovic (CBO).

Apr 2017

American Association for Thoracic Surgery – AATS Centennial, 55th International conference (April 29- May 1, 2017, Boston, MA)

PolyPid will participate at the AATS conference with its product candidate D-PLEX. To learn more about our interim Phase Ib results as well as plans for starting up the Phase III clinical trial in the US, come and visit us at the Booth 831 in the exhibition hall.

Jun 2017

J.P. Morgan 35th Annual Healthcare Conference (January 9-12, 2017)

PolyPid's senior management will attend the J.P. Morgan 35th Annual Healthcare Conference, to be held on January 9-12, 2017 in San Francisco, California, USA.

Nov 2016

Oppenheimer Israel private companies conference (November 13th, 2016)

Dikla Czaczkes Akselbrad, PolyPid’s Chief Strategy Officer, will present PolyPid at the third annual, Oppenheimer Israel promising private companies conference, to be held on November 13th, at the David Intercontinental in Tel Aviv, Israel.

May 2016

ALTernatives to ANTibiotics (ALTANT) Conference (May 18-20, 2016)

PolyPid’s and BALI's (Biofilm Alliance) abstract was accepted to be presented at the Alternatives to Antibiotics (ALTANT) conference to be held on May 18-20, 2016 in Utrecht, The Netherlands. The abstract, titled: "Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing LL-37-derived antimicrobial peptides", will be presented by Dr. Martijn Riool, Research Scientist, University of Amsterdam.

Mar 2016

Dutch Society of Medical Microbiology (KNVM/NVMM) Meeting (March 22, 2016)

PolyPid’s and BALI's (Biofilm Alliance) abstract was accepted to be presented at the Dutch Society of (Medical) Microbiology spring meeting to be held on March 22, 2016 in Papendal, The Netherlands. The abstract, titled: "Polymer‐Lipid Coating Releasing  Novel Antimicrobial Peptides Prevents S. aureus Biomaterial Associated Infection", will be presented by Dr. Martijn Riool, Research Scientist, University of Amsterdam.

Jan 2016

J.P. Morgan 34th Annual Healthcare Conference (January 11-14, 2016)

PolyPid's senior management will attend the J.P. Morgan 34th Annual Healthcare Conference, to be held on January 11-14, 2016 in San Francisco, California, USA.

Dec 2015

COATIM Meeting (December 17, 2015)

PolyPid’s and BALI's (Biofilm Alliance) abstract was accepted to be presented at the final COATIM meeting to be held on December 17, 2015 in Leuven, Belgium. COATIM consortium was established with support from the European Commission (Seventh Framework Program – FP7) in order to develop antibiofilm coatings for implants. The abstract, titled: "Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing the antimicrobial peptide OP-145", will be presented by Dr. Anna de Breij, Research Scientist, Leiden University Medical Center.

Dec 2015

Netherlands Society for Biomaterials and Tissue Engineering (December 3-4, 2015)

PolyPid’s and BALI's (Biofilm Alliance, part of the Seventh Framework Program – FP7) abstract was accepted to be presented at the Netherlands Society for Biomaterials and Tissue Engineering (NBTE) annual meeting to be held on December 3-4, 2015 in Lunteren, Netherlands. The abstract, titled: "Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing the antimicrobial peptide OP-145", will be presented by Dr. Martijn Riool, Research Scientist, University of Amsterdam.

Technology

The PLEX™ (Polymer-Lipid Encapsulation matriX) platform is a matrix made of alternating layers of polymers and lipids that allows controlled, local release of unmodified drugs over extended periods of time.

Read More >

D-PLEX™

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

Read More >

BonyPid-1000™

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >